Taylor Frigon Capital Management LLC trimmed its position in shares of Alteryx, Inc. (NYSE:AYX – Get Rating) by 28.3% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 54,135 shares of the company’s stock after selling 21,370 shares during the quarter. Alteryx makes up 1.6% of Taylor Frigon Capital Management LLC’s portfolio, making the stock its 19th biggest holding. Taylor Frigon Capital Management LLC owned 0.08% of Alteryx worth $3,023,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also made changes to their positions in the stock. Vontobel Holding Ltd. purchased a new stake in shares of Alteryx in the third quarter valued at $232,000. Teacher Retirement System of Texas lifted its position in shares of Alteryx by 5.5% in the third quarter. Teacher Retirement System of Texas now owns 9,934 shares of the company’s stock valued at $555,000 after acquiring an additional 521 shares in the last quarter. Parametrica Management Ltd purchased a new stake in shares of Alteryx in the third quarter valued at $225,000. Ellevest Inc. acquired a new position in Alteryx in the third quarter valued at $32,000. Finally, DekaBank Deutsche Girozentrale acquired a new position in Alteryx in the third quarter valued at $1,642,000. 74.23% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several equities analysts recently commented on the company. JMP Securities dropped their target price on Alteryx from $127.00 to $95.00 and set a “market outperform” rating for the company in a research note on Wednesday, November 2nd. Citigroup upped their target price on Alteryx from $73.00 to $75.00 in a research note on Wednesday, November 2nd. Piper Sandler dropped their target price on Alteryx from $62.00 to $60.00 and set an “overweight” rating for the company in a research note on Monday, January 9th. Wedbush assumed coverage on Alteryx in a research note on Wednesday, December 14th. They set a “neutral” rating and a $50.00 price target for the company. Finally, Truist Financial restated a “buy” rating and set a $80.00 price target on shares of Alteryx in a research note on Friday, November 11th. Five analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, Alteryx currently has an average rating of “Moderate Buy” and an average target price of $72.31.
Insider Transactions at Alteryx
Alteryx Trading Down 3.2 %
Shares of NYSE AYX traded down $1.71 on Wednesday, hitting $52.00. The company had a trading volume of 255,643 shares, compared to its average volume of 845,059. Alteryx, Inc. has a 12-month low of $39.55 and a 12-month high of $76.35. The business has a 50 day moving average of $47.87 and a two-hundred day moving average of $52.93. The company has a debt-to-equity ratio of 5.07, a current ratio of 1.60 and a quick ratio of 1.60.
Alteryx (NYSE:AYX – Get Rating) last issued its earnings results on Tuesday, November 1st. The company reported ($0.95) earnings per share for the quarter, missing the consensus estimate of ($0.65) by ($0.30). Alteryx had a negative return on equity of 103.88% and a negative net margin of 44.55%. The company had revenue of $215.71 million during the quarter, compared to analysts’ expectations of $192.11 million. As a group, research analysts predict that Alteryx, Inc. will post -2.94 EPS for the current fiscal year.
Alteryx Profile
Alteryx, Inc engages in the provision of self-service data analytics software. Its subscription-based platform allows organizations to prepare, blend, and analyze data from a multitude of sources and benefit from data-driven decisions. The company was founded by Dean A. Stoecker, Olivia Duane-Adams, and Edward P.
Recommended Stories
- Get a free copy of the StockNews.com research report on Alteryx (AYX)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- 3 Retail Stocks Ringing the Register in 2023
Want to see what other hedge funds are holding AYX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alteryx, Inc. (NYSE:AYX – Get Rating).
Receive News & Ratings for Alteryx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alteryx and related companies with MarketBeat.com's FREE daily email newsletter.